Burning Rock Biotech Limited (BNR)

Burning Rock Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	463.99	519.85	615.1	905.45	1,431	1,895
Short-Term Investments	-	6.14	13.41	2.09	65.63	367.39
Cash & Short-Term Investments	463.99	525.99	628.5	907.55	1,497	2,263
Cash Growth	-6.82%	-16.31%	-30.75%	-39.37%	-33.84%	450.69%
Accounts Receivable	196.89	165.87	149.61	151.71	134.59	110.75
Other Receivables	-	0.18	1.18	0.1	0.11	2.23
Receivables	196.89	166.05	150.79	151.81	138.2	112.98
Inventory	54.47	62.63	69.02	130.32	123.21	68.02
Restricted Cash	2.99	2.31	0.12	19.82	7.8	29.9
Other Current Assets	20.99	19.65	35.67	49.27	54.79	50.06
Total Current Assets	739.32	776.62	884.1	1,259	1,821	2,524
Property, Plant & Equipment	66.04	100.34	144.2	300.03	406.45	111.48
Long-Term Investments	-	-	0.34	0.69	0.91	1.42
Other Intangible Assets	0.32	0.42	0.96	1.99	5.15	3.46
Other Long-Term Assets	6.49	7.93	5.09	20.89	45.14	23.02
Total Assets	812.17	885.31	1,040	1,587	2,279	2,663
Accounts Payable	34.28	33.75	18.06	50.95	63.08	35.48
Accrued Expenses	76.99	56.94	65.37	104.23	107.03	71.89
Short-Term Debt	-	-	-	-	2.37	7.37
Current Portion of Long-Term Debt	0.2	-	-	-	-	34.7
Current Portion of Leases	16.6	24.57	8.63	37.24	35	4.82
Current Income Taxes Payable	-	14.46	20.62	11.03	7.69	6.99
Current Unearned Revenue	106.45	117.9	130.54	147.63	142.87	74.4
Other Current Liabilities	0.59	18.69	20.14	60.38	14.14	5.89
Total Current Liabilities	235.11	266.3	263.36	411.45	372.18	241.53
Long-Term Debt	1.8	-	-	-	-	-
Long-Term Leases	14.58	27.75	3.69	13.55	49.32	-
Long-Term Unearned Revenue	-	-	-	-	-	0.26
Other Long-Term Liabilities	11.1	10.43	4.54	4.12	11.78	0.23
Total Liabilities	262.59	304.48	271.59	429.13	433.28	242.02
Common Stock	0.14	0.15	0.14	0.14	0.14	0.14
Additional Paid-In Capital	5,007	5,002	4,849	4,583	4,281	4,007
Retained Earnings	-4,240	-4,200	-3,854	-3,200	-2,229	-1,418
Treasury Stock	-57.19	-63.26	-65.9	-58.92	-	-
Comprehensive Income & Other	-160.09	-158.05	-161.53	-165.72	-207.07	-167.59
Total Common Equity	549.58	580.83	768.41	1,158	1,845	2,421
Shareholders' Equity	549.58	580.83	768.41	1,158	1,845	2,421
Total Liabilities & Equity	812.17	885.31	1,040	1,587	2,279	2,663
Total Debt	33.18	52.32	12.32	50.79	86.69	46.88
Net Cash (Debt)	430.81	473.66	616.18	856.76	1,410	2,216
Net Cash Growth	8.50%	-23.13%	-28.08%	-39.25%	-36.35%	545.24%
Net Cash Per Share	-	46.02	60.18	82.45	135.33	322.84
Filing Date Shares Outstanding	-	10.77	10.26	10.27	10.52	10.45
Total Common Shares Outstanding	-	10.76	10.24	10.26	10.51	10.48
Working Capital	504.21	510.32	620.73	847.31	1,449	2,282
Book Value Per Share	-	53.97	75.01	112.85	175.56	231.05
Tangible Book Value	549.26	580.41	767.45	1,156	1,840	2,418
Tangible Book Value Per Share	-	53.93	74.92	112.66	175.07	230.72
Machinery	-	307.49	348.07	339.09	297.89	180.54
Construction In Progress	-	0.63	0.55	2.66	27.56	1.09
Leasehold Improvements	-	187.23	187.39	187.38	161.04	30.67

Updated Nov 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q